Peter Lio, MD: Innovations in JAK Inhibitors

Peter Lio, MD, of Medical Dermatology Associates of Chicago in Chicago, Illinois, discusses recent innovations in atopic dermatitis therapies with regard to JAK inhibitors. Dr. Lio discusses several new drugs in this class, including topical ruxolitinib, oral abrocitinib, and oral upadacitinib, and provides important guidance for practitioners treating their patients with these new therapies.

AAD 2022 Meeting Coverage

Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone therapies for melasma.

Susan Taylor, MD: Skin of Color Curriculum

Dr. Taylor discusses the gaps in dermatology education regarding skin of color and introduces the Skin of Color curriculum now available online at the AAD Learning Center.